Evidence map›Paper›PMID 36464647›Full record

ReviewHistopathology2023

Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Judith V M G Bovée, Fleur Webster, Fernanda Amary, Daniel Baumhoer, J L Hans Bloem, Julia A Bridge, Justin M M Cates, Enrique de Alava, Angelo Paolo Dei Tos, Kevin B Jones and 6 more

Abstract readReview
In one paragraph

Review in Histopathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Guideline
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Judith V M G BovéeDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0003-1155-0481
Fleur WebsterInternational Collaboration on Cancer Reporting, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0001-8706-0388
Fernanda AmaryDepartment of Histopathology, Royal National Orthopaedic Hospital, Stanmore, Greater London, UK.ORCID https://orcid.org/0000-0002-6707-8246
Daniel BaumhoerBone Tumour Reference Centre, Institute of Pathology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-2137-7507
J L Hans BloemDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Julia A BridgeDivision of Molecular Pathology, ProPath, Dallas, TX, USA.
Justin M M CatesDepartment of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-7336-5196
Enrique de AlavaInstitute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital, CSIC, University of Seville, Seville, Spain.ORCID https://orcid.org/0000-0001-8400-046X
Angelo Paolo Dei TosDepartment of Pathology, Azienda Ospedaliera Universitaria di Padova, Padova, Italy.ORCID https://orcid.org/0000-0002-1228-8940
Kevin B JonesDepartment of Orthopaedics, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Annabelle MaharDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
G Petur NielsenDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.ORCID https://orcid.org/0000-0002-9671-7211
Alberto RighiDepartment of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.ORCID https://orcid.org/0000-0002-1074-0155
Andrew J WagnerHarvard Medical School, Boston, MA, USA.
Akihiko YoshidaDepartment of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3373-0099
Christopher D M FletcherDepartment of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesBone tumours are relatively rare and, as a consequence, treatment in a centre with expertise is required. Current treatment guidelines also recommend review by a specialised pathologist. Here we report on international consensus-based datasets for the pathology reporting of biopsy and resection specimens of bone sarcomas. The datasets were produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of major (inter-)national pathology and cancer organisations. METHODS AND

resultsAccording to the ICCR's process for dataset development, an international expert panel consisting of pathologists, an oncologic orthopaedic surgeon, a medical oncologist, and a radiologist produced a set of core and noncore data items for biopsy and resection specimens based on a critical review and discussion of current evidence. All professionals involved were bone tumour experts affiliated with tertiary referral centres. Commentary was provided for each data item to explain the rationale for selecting it as a core or noncore element, its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the documents were finalised and ratified, and the datasets, including a synoptic reporting guide, were published on the ICCR website.

conclusionThese first international datasets for bone sarcomas are intended to promote high-quality, standardised pathology reporting. Their widespread adoption will improve the consistency of reporting, facilitate multidisciplinary communication, and enhance comparability of data, all of which will help to improve management of bone sarcoma patients.

Indexed as

Pathology, ClinicalSarcomaBiopsyHumansMedical Oncologybone sarcomadata managementdata registrationdatasetguidelinesICCRstructured reportsynoptic report

Identifiers

PMID36464647
PMCPMC10107487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.